← Home
Stryker Corp.
Healthcare & biotech / Orthopedics, medical and surgical, and neurotechnology and spine applications
Cash Flow Statement
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Net Income | Depreciation And Amortization | Deferred Income Tax | Stock Based Compensation | Change In Working Capital | Accounts Receivables | Inventory | Accounts Payables | Other Working Capital | Other Non Cash Items | Net Cash Provided By Operating Activities | Investments In Property Plant And Equipment | Acquisitions Net | Purchases Of Investments | Sales Maturities Of Investments | Other Investing Activities | Net Cash Used For Investing Activities | Debt Repayment | Common Stock Issued | Common Stock Repurchased | Dividends Paid | Other Financing Activities | Net Cash Used Provided By Financing Activities | Effect Of Forex Changes On Cash | Net Change In Cash | Cash At End Of Period | Cash At Beginning Of Period | Operating Cash Flow | Capital Expenditure |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 2993.0 | 1050.0 | -370.0 | 229.0 | 0.0 | -321.0 | 46.0 | 192.0 | 0.0 | 340.0 | 4242.0 | -755.0 | -1628.0 | -808.0 | 148.0 | 43.0 | -3000.0 | 940.0 | 0.0 | 0.0 | -1219.0 | -246.0 | -525.0 | -36.0 | 681.0 | 3652.0 | 2971.0 | 4242.0 | -755.0 |
2023-12 | 3165.0 | 1028.0 | -206.0 | 205.0 | -500.0 | -175.0 | -797.0 | 77.0 | 395.0 | 19.0 | 3711.0 | -575.0 | -390.0 | -52.0 | 54.0 | 1.0 | -962.0 | -277.0 | 0.0 | -155.0 | -1139.0 | -178.0 | -1594.0 | -28.0 | 1127.0 | 2971.0 | 1844.0 | 3711.0 | -575.0 |
2022-12 | 2358.0 | 998.0 | 58.0 | 168.0 | -732.0 | -579.0 | -762.0 | 290.0 | 319.0 | -226.0 | 2624.0 | -588.0 | -2563.0 | -52.0 | 240.0 | 39.0 | -2924.0 | 472.0 | 0.0 | -122.0 | -1051.0 | -170.0 | -749.0 | -51.0 | -1100.0 | 1844.0 | 2944.0 | 2624.0 | -588.0 |
2021-12 | 1994.0 | 990.0 | -237.0 | 171.0 | 279.0 | -377.0 | -189.0 | 329.0 | 516.0 | 66.0 | 3263.0 | -525.0 | -339.0 | -49.0 | 55.0 | -1.0 | -859.0 | -1146.0 | 114.0 | -114.0 | -950.0 | -269.0 | -2365.0 | -38.0 | 1.0 | 2944.0 | 2943.0 | 3263.0 | -525.0 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
